Status:
ACTIVE_NOT_RECRUITING
Efficacy of a Self-advocacy Serious Game Intervention
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Self-Management
Quality of Life
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Individuals with cancer must overcome multiple, ongoing challenges ("self-advocate") related to their cancer experience to receive patient-centered care. Women with metastatic cancer often face signif...
Detailed Description
Patient-centered care (e.g., incorporating patient preferences, needs, and values into all care aspects) is an essential component of high-quality care, associated with improved patient health, well-b...
Eligibility Criteria
Inclusion
- Female
- ≥18 years
- Diagnosed with advanced solid organ cancer within the past 6 months being treated with non-curative intent
- Have at least a 6-month life expectancy (as determined by their oncologist)
- Eastern Cooperative Oncology Group performance score of 0 to 2 (per health record or oncologist)
- Able to read and write in English
Exclusion
- On hospice at the time of recruitment
- Impaired cognition (per health record)
- Other active, unstable mental health disorder
Key Trial Info
Start Date :
August 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
336 Patients enrolled
Trial Details
Trial ID
NCT04813276
Start Date
August 22 2022
End Date
December 31 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232